These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 38567148)
41. Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer. Liu M; Mao N; Ma H; Dong J; Zhang K; Che K; Duan S; Zhang X; Shi Y; Xie H Cancer Imaging; 2020 Sep; 20(1):65. PubMed ID: 32933585 [TBL] [Abstract][Full Text] [Related]
42. Radiomics in cone-beam breast CT for the prediction of axillary lymph node metastasis in breast cancer: a multi-center multi-device study. Zhu Y; Ma Y; Zhai Z; Liu A; Wang Y; Zhang Y; Li H; Zhao M; Han P; Yin L; He N; Wu Y; Sechopoulos I; Ye Z; Caballo M Eur Radiol; 2024 Apr; 34(4):2576-2589. PubMed ID: 37782338 [TBL] [Abstract][Full Text] [Related]
43. A nomogram based on conventional and contrast-enhanced ultrasound radiomics for the noninvasively prediction of axillary lymph node metastasis in breast cancer patients. Sun C; Gong X; Hou L; Yang D; Li Q; Li L; Wang Y Front Oncol; 2024; 14():1400872. PubMed ID: 38800371 [TBL] [Abstract][Full Text] [Related]
44. Prediction of pelvic lymph node metastasis in prostate cancer using radiomics based on T Liu X; Zhang Y; Sun Z; Wang X; Zhang X; Wang X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1025-1036. PubMed ID: 36097770 [TBL] [Abstract][Full Text] [Related]
45. Prediction of Axillary Lymph Node Metastasis in Breast Cancer using Intra-peritumoral Textural Transition Analysis based on Dynamic Contrast-enhanced Magnetic Resonance Imaging. Zhan C; Hu Y; Wang X; Liu H; Xia L; Ai T Acad Radiol; 2022 Jan; 29 Suppl 1():S107-S115. PubMed ID: 33712393 [TBL] [Abstract][Full Text] [Related]
46. Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI. Niu S; Jiang W; Zhao N; Jiang T; Dong Y; Luo Y; Yu T; Jiang X J Cancer Res Clin Oncol; 2022 Jan; 148(1):97-106. PubMed ID: 34623517 [TBL] [Abstract][Full Text] [Related]
47. Non-Mass Enhancements on DCE-MRI: Development and Validation of a Radiomics-Based Signature for Breast Cancer Diagnoses. Li Y; Yang ZL; Lv WZ; Qin YJ; Tang CL; Yan X; Guo YH; Xia LM; Ai T Front Oncol; 2021; 11():738330. PubMed ID: 34631572 [TBL] [Abstract][Full Text] [Related]
48. Could Ultrasound-Based Radiomics Noninvasively Predict Axillary Lymph Node Metastasis in Breast Cancer? Qiu X; Jiang Y; Zhao Q; Yan C; Huang M; Jiang T J Ultrasound Med; 2020 Oct; 39(10):1897-1905. PubMed ID: 32329142 [TBL] [Abstract][Full Text] [Related]
49. Intra- and peritumoral radiomics for predicting malignant BiRADS category 4 breast lesions on contrast-enhanced spectral mammography: a multicenter study. Zhang S; Shao H; Li W; Zhang H; Lin F; Zhang Q; Zhang H; Wang Z; Gao J; Zhang R; Gu Y; Wang Y; Mao N; Xie H Eur Radiol; 2023 Aug; 33(8):5411-5422. PubMed ID: 37014410 [TBL] [Abstract][Full Text] [Related]
50. Radiomic Machine Learning in Invasive Ductal Breast Cancer: Prediction of Ki-67 Expression Level Based on Radiomics of DCE-MRI. Yang H; Wang W; Cheng Z; Zheng T; Cheng C; Cheng M; Wang Z Technol Cancer Res Treat; 2024; 23():15330338241288751. PubMed ID: 39431304 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of Lymphatic Vessel Invasion Determined by D2-40 Using Preoperative MRI-Based Radiomics for Invasive Breast Cancer. Wu Z; Lin Q; Song H; Chen J; Wang G; Fu G; Cui C; Su X; Li L; Bian T Acad Radiol; 2023 Nov; 30(11):2458-2468. PubMed ID: 36586760 [TBL] [Abstract][Full Text] [Related]
52. Radiomics analysis of intratumoral and different peritumoral regions from multiparametric MRI for evaluating HER2 status of breast cancer: A comparative study. Zhou J; Yu X; Wu Q; Wu Y; Fu C; Wang Y; Hai M; Tan H; Wang M Heliyon; 2024 Apr; 10(7):e28722. PubMed ID: 38623231 [TBL] [Abstract][Full Text] [Related]
53. Ultrasound radiomics based on axillary lymph nodes images for predicting lymph node metastasis in breast cancer. Tang YL; Wang B; Ou-Yang T; Lv WZ; Tang SC; Wei A; Cui XW; Huang JS Front Oncol; 2023; 13():1217309. PubMed ID: 37965477 [TBL] [Abstract][Full Text] [Related]
54. Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients. Li Q; Song Z; Zhang D; Li X; Liu Q; Yu J; Li Z; Zhang J; Ren X; Wen Y; Tang Z Front Oncol; 2022; 12():992906. PubMed ID: 36276058 [TBL] [Abstract][Full Text] [Related]
55. Radiomics nomogram of contrast-enhanced spectral mammography for prediction of axillary lymph node metastasis in breast cancer: a multicenter study. Mao N; Yin P; Li Q; Wang Q; Liu M; Ma H; Dong J; Che K; Wang Z; Duan S; Zhang X; Hong N; Xie H Eur Radiol; 2020 Dec; 30(12):6732-6739. PubMed ID: 32607630 [TBL] [Abstract][Full Text] [Related]
56. Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma. Zhao Y; Zhang J; Wang N; Xu Q; Liu Y; Liu J; Zhang Q; Zhang X; Chen A; Chen L; Sheng L; Song Q; Wang F; Guo Y; Liu A BMC Cancer; 2023 Oct; 23(1):1026. PubMed ID: 37875815 [TBL] [Abstract][Full Text] [Related]
57. Radiomics analysis for prediction of lymph node metastasis after neoadjuvant chemotherapy based on pretreatment MRI in patients with locally advanced cervical cancer. Liu J; Dong L; Zhang X; Wu Q; Yang Z; Zhang Y; Xu C; Wu Q; Wang M Front Oncol; 2024; 14():1376640. PubMed ID: 38779088 [TBL] [Abstract][Full Text] [Related]
58. Machine learning models for differential diagnosing HER2-low breast cancer: A radiomics approach. Chen X; Li M; Su D Medicine (Baltimore); 2024 Aug; 103(33):e39343. PubMed ID: 39151526 [TBL] [Abstract][Full Text] [Related]
59. DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma. Zheng J; Du PZ; Yang C; Tao YY; Li L; Li ZM; Yang L Abdom Radiol (NY); 2023 Nov; 48(11):3343-3352. PubMed ID: 37495746 [TBL] [Abstract][Full Text] [Related]
60. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer. Bian X; Du S; Yue Z; Gao S; Zhao R; Huang G; Guo L; Peng C; Zhang L J Magn Reson Imaging; 2023 Nov; 58(5):1603-1614. PubMed ID: 36763035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]